Companies Dominating the Soft Tissue Allografts Landscape
- Stryker Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ALON SOURCE GROUP
- CONMED Corporation
- LifeSciences Corporation
- Organogenesis Inc.
- RTI Surgical, Inc.
- MIMEDX, Inc.
- Xtant Medical Holdings, Inc.
- Globus Medical, Inc.
- Bone Bank Allografts
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Soft Tissue Allografts Market in 2025 is evaluated at USD 4.83 billion.
The global market size was worth over USD 4.58 billion in 2024 and is poised to grow at a CAGR of around 6.7%, reaching USD 10.64 billion revenue by 2037.
North America holds the largest share, fueled by the rising prevalence of arthritis and healthcare expenditure on its treatment.
The major players in the market include Stryker Corporation, ALON SOURCE GROUP, CONMED Corporation, LifeSciences Corporation, Organogenesis Inc., RTI Surgical, Inc., MIMEDX, Inc., Xtant Medical Holdings, Inc., Globus Medical, Inc., Bone Bank Allografts
